Salvador Aznar Benitah's research, "one more step in understanding how cancer works"

Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)

Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)


WCAX-TV, the television station in Burlington (Vermont, USA), devotes a report to a study on cancer, headed by Salvador Aznar Benitah, ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona.  The study reports that in mice a specific protein called CD36 absorbs fat from the cell membrane and is the agent that determines whether the cancer grows elsewhere in the body. The study demonstrates the anti-metastatic effect of blocking the CD36 protein in mice.

Based on their findings, Salvador Aznar Benitah's group is now working to develop treatments. "We are taking a group of patients with oral cancer and spitting them into two groups. One group will go on a diet with very low levels of palmitic acid while the other will be on a controlled diet, with a standard amount of fat. This will allow us to compare the effect of the two diets," said Salvador Aznar Benitah. 

Link to WCAX-TV